| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/27/1988 | CN87106696A Proteins and process for preparing them, adn sequence, antibodys and their application, poxvirus, transformed or infected cells used as pharmaceutical comg |
| 04/27/1988 | CN87104424A Human erythropoietin gene high level expression in stably transfected mammalian cells |
| 04/27/1988 | CN86108977A N-amide glucuromide glycoside antibiotic a40926 group and glycoside antibiotic a40926 |
| 04/26/1988 | US4740593 Derived nisin producing microorganisms, method of production and use and products obtained thereby |
| 04/26/1988 | US4740588 For myristoylating enzymes |
| 04/26/1988 | US4740462 Non-phosphorylated peptides from casein-based material |
| 04/26/1988 | US4740304 Composition for use in a twophase or multiphase system |
| 04/26/1988 | EP0192679A4 Yeast cloning vehicles. |
| 04/26/1988 | CA1235667A1 Stabilization of unstably inherited plasmids |
| 04/21/1988 | WO1988002863A1 Kit of material containing a polypeptide of pancreatic islet amyloid and/or antibodies directed against said polypeptide; and use of said kit of material |
| 04/21/1988 | WO1988002778A1 Method for the production of proteins by means of inducible expression systems in genetically modified eukaryotic host-cells multiplicated in-vivo |
| 04/21/1988 | WO1988002755A1 Glycopeptide antibiotics |
| 04/21/1988 | WO1988002631A1 IgE-INDUCED REGULANT (EIR) COMPOSITIONS |
| 04/21/1988 | WO1988002594A2 Methods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereof |
| 04/21/1988 | WO1988000200A3 Process for the preparation of antibiotics 10381b |
| 04/21/1988 | DE3735380A1 Verfahren zur herstellung von photoprotein aequorin unter verwendung eines expressionsvektors, der an der aussenseite des bakterienkoerpers von escherichia coli abgeschieden werden soll Process for the preparation of photoprotein aequorin using an expression vector that is to be deposited on the outside of the bakterienkoerpers of Escherichia coli |
| 04/20/1988 | EP0264250A2 Process for transforming a human insulin precursor to human insulin |
| 04/20/1988 | EP0264219A2 Receptors for immune complexes, their methods of production and assay methods using them |
| 04/20/1988 | EP0264166A1 Transgenic animals secreting desired proteins into milk |
| 04/20/1988 | EP0263933A1 A cDNA coding for carcinoembryonic antigen |
| 04/20/1988 | EP0263908A1 Method for the production of proteins by means of inducible expression systems in genetically modified eukaryotic host-cells multiplicated in-vivo |
| 04/20/1988 | EP0263902A1 Solubilisation and oxidation of somatotropin from transformed microorganisms |
| 04/20/1988 | EP0263847A1 Methods and compositions relating to regression-associated antigens |
| 04/20/1988 | EP0053135B1 Production of ifn-gamma |
| 04/20/1988 | CN87106876A Antibiotics |
| 04/20/1988 | CN87102945A Pre-s gene coded peptide hepatilis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 04/19/1988 | US4738926 Method for purification of HBs antigen |
| 04/19/1988 | US4738922 Trans-acting transcriptional factors |
| 04/19/1988 | US4738921 Shortened encoding sequence |
| 04/19/1988 | US4738845 Viricides, antitumor agents |
| 04/19/1988 | US4738844 Antivcral, antitumor, immunomodulatory agents |
| 04/18/1988 | EP0188555A4 Yeast cloning vehicle. |
| 04/13/1988 | EP0263802A1 Kit of material containing a polypeptide of pancreatic islet amyloid and/or antibodies directed against said polypeptide, and use of said kit of material |
| 04/13/1988 | EP0263591A2 Recombinant vaccinia virus |
| 04/13/1988 | EP0263526A1 Method of purifying toxin conjugates using hydrophobic interaction chromatography |
| 04/13/1988 | EP0263518A2 Purification of recombinant tumor necrosis factor |
| 04/13/1988 | EP0263502A2 Oligopeptide antibiotics |
| 04/13/1988 | EP0263311A2 Yeast production of human tumor necrosis factor |
| 04/13/1988 | EP0263135A1 Antiparatypical antibodies, their use for detecting and treating auto-immune diseases |
| 04/13/1988 | EP0263102A1 A cDNA MOLECULE CODING FOR THE EXPRESSION OF AN INTERFERON $g(a) TYPE POLYPEPTIDE, A BACTERIAL OR CELLULAR HOST TRANSFORMED WITH SUCH MOLECULE AND A POLYPEPTIDE SHOWING INTERFERON ACTIVITY PREPARED BY SUCH HOST |
| 04/12/1988 | US4737579 Diagnosis, therapy |
| 04/12/1988 | US4737455 Analytical utilization of phagocyte cell lines |
| 04/12/1988 | CA1235118A1 Assay for qualitatively and/or quantitatively measuring hlh or hcg body fluids and reagents therefor |
| 04/12/1988 | CA1235078A1 Monoclonal antibodies, to bovine serum albumin and their use in bsa isolation |
| 04/07/1988 | WO1988002407A1 Recombinant dna clone encoding laminin receptor |
| 04/07/1988 | WO1988002406A2 Methods of regulating metabolic stability of proteins |
| 04/07/1988 | WO1988002403A1 Cloning and expression of the 47-kilodalton antigen of treponema pallidum |
| 04/07/1988 | WO1988002402A1 Intracellular directed delivery of expression products |
| 04/07/1988 | WO1988002401A1 Recombinant pseudomanas exotoxin: construction of an active immunotoxin with low side effects |
| 04/07/1988 | WO1988001298A3 Enzymatic membrane method for the synthesis and separation of peptides |
| 04/07/1988 | WO1988000204A3 Polypeptide competitor for immunoglobulin e |
| 04/07/1988 | WO1987006617A3 Detection of a unique chlamydia strain associated with acute respiratory disease |
| 04/06/1988 | EP0263086A1 Binding-inducing composition |
| 04/06/1988 | EP0263072A2 Novel lymphokine related peptides |
| 04/06/1988 | EP0262854A2 Assay method and diagnostic system for a marker of abnormal lipid metabolism |
| 04/06/1988 | EP0262710A1 Use of a peptide for the preparation of compositions for the alleviation, treatment and diagnosis of autoimmune diseases, especially arthritic conditions, compounds related to said peptide, micro-organisms expressing said peptide or a compound related to said peptide, as well as pharmaceutical and diagnostic compositions and test kits |
| 04/06/1988 | EP0262571A2 Monoclonal antibodies against IFN-omega, process for preparing them and their use in the purification and detection of IFN-omega |
| 04/05/1988 | USRE32637 Antigrowth agent, viricide |
| 04/05/1988 | US4735898 Monoclonal antibodies and method of identifying species using the same |
| 03/30/1988 | EP0262043A1 DNA sequence vectors, recombinant viruses and method of using recombinant vaccinia viruses capable of multiplying in CHO cells |
| 03/30/1988 | EP0261940A2 Pseudorabies vaccines and DNA vectors for recombination with pox viruses |
| 03/30/1988 | EP0261936A2 Process for producing glycopeptide antibiotic |
| 03/30/1988 | EP0261671A2 Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects |
| 03/30/1988 | EP0261648A2 Cell membrane proteins, compositions containing them and procedure for their preparation |
| 03/30/1988 | EP0261625A2 Human B-cell differentiation factor and process of producing said factor |
| 03/30/1988 | EP0261592A1 Gene coding for human colony-stimulating factors |
| 03/30/1988 | EP0261552A1 Genetic engineering method to produce salmon calcitonin, and means to carry out this method |
| 03/30/1988 | EP0261239A1 Fsh-releasing peptide. |
| 03/29/1988 | US4734491 DNA sequences encoding hybrid lymphoblastoid-leukocyte human interferons |
| 03/29/1988 | US4734403 Membrane polysaccharides which are useful as immunostimulants |
| 03/29/1988 | US4734399 Growth hormone releasing factor analogs |
| 03/29/1988 | US4734362 Process for purifying recombinant proteins, and products thereof |
| 03/24/1988 | WO1988002030A1 Method for producing a heterologous protein in insect cells |
| 03/24/1988 | WO1988002029A1 Messenger rna stabilization in animal cells |
| 03/24/1988 | WO1988002028A1 Monoclonal antibodies and their use |
| 03/24/1988 | WO1988002006A1 Monoclonal antibody specific to tumor cell surface ganglioside and hybridoma yielding same |
| 03/24/1988 | WO1988002005A1 Insulin precursors |
| 03/23/1988 | EP0261009A1 DNA sequence exercizing a function characterized by an overproduction of extracellular proteins from different bacillus strains, and vectors containing this sequence |
| 03/23/1988 | EP0260939A2 Molecules with antibody combining sites that exhibit catalytic properties |
| 03/23/1988 | EP0260919A1 L-phenylalanine ammonia lyase |
| 03/23/1988 | EP0260918A2 Megakaryocyte stimulatory factor |
| 03/23/1988 | EP0260829A2 Antibodies reactive with chlorinated phenols and methods of preparing and using same |
| 03/23/1988 | EP0260715A2 Monoclonal antibody |
| 03/23/1988 | EP0260610A2 Monoclonal antibodies against human tumour necrotic factor (TNF), and their use |
| 03/23/1988 | EP0260497A2 Lectin like protein substance having anti-tumor action |
| 03/23/1988 | EP0260404A2 Amylolytic enzymes producing microorganisms constructed by recombinant DNA technology and their use for fermentation processes |
| 03/23/1988 | EP0260299A1 Mutagenesis and screening method and product |
| 03/23/1988 | EP0260290A1 New fluorine-containing surfactants derived from proteinic substances; method for obtaining them and utilisation thereof |
| 03/23/1988 | EP0260277A1 Method for the extraction of a vitamin-k-dependent carboxylase complex and the use thereof |
| 03/23/1988 | EP0233915A4 Molecular farming. |
| 03/22/1988 | US4732971 Synthetic vaccines for foot and mouth disease |
| 03/22/1988 | US4732859 Method for conferring bacteriophage resistance to bacteria |
| 03/22/1988 | EP0218692A4 Von willebrand factor. |
| 03/22/1988 | CA1234363A1 Monoclonal antibodies to surface recognition structure of mature human t lymphocyte clone |
| 03/16/1988 | EP0260149A1 Human prorelaxin for therapeutic use |
| 03/16/1988 | EP0260148A2 Improved recombinant expression method, vector and transformed cells |
| 03/16/1988 | EP0259953A1 Cloning and expression of acidic fibroblast growth factor |
| 03/16/1988 | EP0259891A2 [Leu 13] motilin, DNAs coding for same and methods for producing same |
| 03/16/1988 | EP0259807A2 Complement-dependent cytolytic anti-trichomonas vaginalis monoclonal antibody and use thereof in therapy and in diagnosis |
| 03/16/1988 | EP0259781A2 Method for selectively increasing the ratio of single major components of antibiotic A 40926 complex |